127 related articles for article (PubMed ID: 14533796)
1. Red blood cell antigens responsible for inherited types of polyagglutination.
Lisowska E; Duk M
Adv Exp Med Biol; 2001; 491():141-53. PubMed ID: 14533796
[TBL] [Abstract][Full Text] [Related]
2. Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.
Duk M; Kusnierz-Alejska G; Korchagina EY; Bovin NV; Bochenek S; Lisowska E
Glycobiology; 2005 Feb; 15(2):109-18. PubMed ID: 15342552
[TBL] [Abstract][Full Text] [Related]
3. Specificity of human anti-NOR antibodies, a distinct species of "natural" anti-alpha-galactosyl antibodies.
Duk M; Westerlind U; Norberg T; Pazynina G; Bovin NN; Lisowska E
Glycobiology; 2003 Apr; 13(4):279-84. PubMed ID: 12626386
[TBL] [Abstract][Full Text] [Related]
4. HEMPAS disease: genetic defect of glycosylation.
Fukuda MN
Glycobiology; 1990 Sep; 1(1):9-15. PubMed ID: 2136385
[TBL] [Abstract][Full Text] [Related]
5. Structure of a neutral glycosphingolipid recognized by human antibodies in polyagglutinable erythrocytes from the rare NOR phenotype.
Duk M; Reinhold BB; Reinhold VN; Kusnierz-Alejska G; Lisowska E
J Biol Chem; 2001 Nov; 276(44):40574-82. PubMed ID: 11504714
[TBL] [Abstract][Full Text] [Related]
6. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
Fukuda MN; Masri KA; Dell A; Thonar EJ; Klier G; Lowenthal RM
Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036
[TBL] [Abstract][Full Text] [Related]
7. Red cell membrane diseases and blood group abnormalities.
Cartron JP; Salmon C
Rev Fr Transfus Immunohematol; 1983 Dec; 26(6):599-623. PubMed ID: 6426027
[No Abstract] [Full Text] [Related]
8. Isolation and characterization of poly-N-acetyllactosaminylceramides accumulated in the erythrocytes of congenital dyserythropoietic anemia type II patients.
Fukuda MN; Bothner B; Scartezzini P; Dell A
Chem Phys Lipids; 1986 Dec; 42(1-3):185-97. PubMed ID: 3829205
[TBL] [Abstract][Full Text] [Related]
9. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.
Fukuda MN; Masri KA; Dell A; Luzzatto L; Moremen KW
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7443-7. PubMed ID: 2217175
[TBL] [Abstract][Full Text] [Related]
10. Structures of unique globoside elongation products present in erythrocytes with a rare NOR phenotype.
Duk M; Singh S; Reinhold VN; Krotkiewski H; Kurowska E; Lisowska E
Glycobiology; 2007 Mar; 17(3):304-12. PubMed ID: 17118951
[TBL] [Abstract][Full Text] [Related]
11. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.
Zdebska E; Mendek-Czajkowska E; Ploski R; Woêniewicz B; Koscielak J
Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161
[TBL] [Abstract][Full Text] [Related]
12. Primary structure of the oligosaccharide determinant of blood group Cad specificity.
Blanchard D; Cartron JP; Fournet B; Montreuil J; van Halbeek H; Vliegenthart JF
J Biol Chem; 1983 Jun; 258(12):7691-5. PubMed ID: 6190803
[TBL] [Abstract][Full Text] [Related]
13. Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes.
Dhume ST; Adams-Burton CR; Shumak KH; Laine RA
Glycobiology; 1994 Dec; 4(6):903-8. PubMed ID: 7734852
[TBL] [Abstract][Full Text] [Related]
14. NOR polyagglutination and Sta glycophorin in one family: relation of NOR polyagglutination to terminal alpha-galactose residues and abnormal glycolipids.
Kuśnierz-Alejska G; Duk M; Storry JR; Reid ME; Wiecek B; Seyfried H; Lisowska E
Transfusion; 1999 Jan; 39(1):32-8. PubMed ID: 9920164
[TBL] [Abstract][Full Text] [Related]
15. Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS).
Fukuda MN; Papayannopoulou T; Gordon-Smith EC; Rochant H; Testa U
Br J Haematol; 1984 Jan; 56(1):55-68. PubMed ID: 6538436
[TBL] [Abstract][Full Text] [Related]
16. Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS).
Fukuda MN; Gaetani GF; Izzo P; Scartezzini P; Dell A
Br J Haematol; 1992 Dec; 82(4):745-52. PubMed ID: 1482662
[TBL] [Abstract][Full Text] [Related]
17. Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated.
Zdebska E; Adamczyk-Popławska M; Kościelak J
Acta Biochim Pol; 2000; 47(3):773-9. PubMed ID: 11310976
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
19. Polyagglutination NOR: new glycosphingolipid antigens recognized by a new type of common human anti-alpha-galactosyl antibodies.
Lisowska E; Duk M
Arch Biochem Biophys; 2004 Jun; 426(2):142-7. PubMed ID: 15158664
[No Abstract] [Full Text] [Related]
20. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)].
Parsons SF; Jones J; Anstee DJ; Judson PA; Gardner B; Wiener E; Poole J; Illum N; Wickramasinghe SN
Blood; 1994 Feb; 83(3):860-8. PubMed ID: 7507739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
